The PennZone

  • Home
  • Business
  • Health
  • Technology
  • Non-profit
  • Financial
  • Construction
  • Sports
  • Services

Phinge's Netverse to Redefine Clinical Trial Safety and Data Integrity with Netverse Patented, Hardware-Verified Platform
The PennZone/10320862

Trending...
  • T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
  • Inside the Fight for Affordable Housing: Avery Headley Joins Terran Lamp for a Candid Bronx Leadership Conversation
  • $80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
Phonebook, Magnetically Connectable Smartphones Smartwatches With Interchangeable Battery Bezels Textbook PairX, Magnetically Connectable Tablets Textbook Triple-Screen Laptop NetverseAI, Verified AI for Users and Businesses Phinge Corporation
LAKE TAHOE, Nev. - PennZone -- Phinge Corporation, the innovator behind the upcoming patented, app-less Netverse® platform, today announced that its technology is poised to revolutionize the clinical trial landscape. By integrating hardware-verified identity, end-to-end encryption, and individual user data ownership, Phinge will address long-standing vulnerabilities in patient safety, data integrity, and privacy that plague the medical research industry.

The company's advancements, supported by patents developed by inventor Robert C. DeMaio, will fundamentally shift the paradigm of data security. The traditional centralized model, which often leads to identity fraud and large-scale data breaches, will be replaced by a decentralized, zero-trust framework where the individual is the sole custodian of their data.

"Clinical research is built on trust—trust from participants, researchers, and regulators. Our Netverse platform will provide the technology to rebuild and strengthen that trust from the ground up," said Phinge CEO Robert DeMaio. "By anchoring patient identity to physical hardware and giving users complete control over their information, we can make clinical trials safer, more efficient, and more inclusive."

Key benefits for the clinical trial industry include:

Elimination of Patient Enrollment Fraud:
Phinge® patented hardware-verified identity will ensure that each participant is a unique, real individual, preventing fraudulent enrollment by "professional subjects" and enhancing the integrity of trial results.
  • Enhanced Data Integrity and Accuracy: Data from verified Phinge IoT devices, such as its patented magnetically connectable smartphones and smartwatches, is automatically collected with an immutable, hardware-verified signature. This will eliminate manual data entry, reducing transcription errors and ensuring a reliable audit trail.
  • Real-time Patient Safety Monitoring: Continuous and objective data collection will allow for instant detection and reporting of adverse events. This will enable researchers to identify safety signals faster and intervene proactively, significantly improving patient safety throughout the study.
  • Empowering Participant Engagement: By owning their personal health data, participants become active stakeholders in their own health journey. This transparency and control will lead to higher engagement and retention rates, addressing a critical challenge in long-term studies.
  • Secure and Granular Data Access: The Netverse platform will feature a robust, granular consent system. Participants can explicitly grant and revoke access to specific data types and for defined time periods, ensuring their information is never shared without their permission. This is a dramatic shift from traditional all-or-nothing data sharing agreements.
  • Monetization of De-identified Data: With explicit consent, participants can choose to monetize their anonymized health data for research purposes. This will provide a direct financial incentive for participation, fostering greater transparency and compensating individuals for their contribution to medical advancements.
Phinge's Netverse will not be just a technology upgrade; it represents a philosophical shift toward a more ethical and participant-centric model for medical research. By making clinical trials safer, more secure, and more transparent, Phinge aims to accelerate the development of new and life-saving treatments.

More on The PennZone
  • Philadelphia Startup NoPlex Creates an ADHD/Neurodiversity-Focused Alternative to Productivity Apps
  • Tiger-Rock Martial Arts Appoints Jami Bond as Vice President of Growth
  • Super League (N A S D A Q: SLE) Enters Breakout Phase: New Partnerships, Zero Debt & $20 Million Growth Capital Position Company for 2026 Acceleration
  • Finland's Gambling Reform Promises "Single-Click" Block for All Licensed Sites
  • Private Keys Are a Single Point of Failure: Security Advisor Gideon Cohen Warns MPC Technology Is Now the Only Defense for Institutional Custody

Preview Netverse and its patented, magnetically attachable smartphones and devices by visiting Phinge's websites at

https://www.phinge.com

To get on a contact list, please fill out the online form here
https://www.phinge.com/netverseai.html

Ask Google Gemini about Netverse here
https://www.phinge.com/get-netverse.html

View Phinge's Crunchbase profile here
https://www.crunchbase.com/organization/phinge

View Phinge CEO Robert DeMaio's Crunchbase profile here
https://www.crunchbase.com/person/robert-charles-demaio

About Phinge Corporation


Phinge was founded and through Netverse® is being developed to disrupt today's outdated App technologies, including the App-store duopoly, by partnering with and giving its users and businesses ownership and control of their data, enhanced privacy and a better overall mobile experience including their ability to monetize it.

Phinge through its upcoming patented Netverse App-less technology platform with proprietary AI, will be a better, safer, verified and rewarding alternative platform and technology for users and third party businesses and developers to today's App stores, operating systems and ecosystems of Apple, Google and Android.

Netverse will not be an App or Super App that resides on the major technology platforms of today.

Instead, it will be a standalone, all-in-one, app-less platform, accessible only through Phinge's revolutionary, patented, Mobile Hardware which includes Magnetically Attachable/Detachable Phones, Tablets, Mobile Gaming Systems and peripherals like the stylish, wireless earbuds with interchangeable batteries and built-in sensor screens for continuous usage without recharging. Smart Watches that never need to be physically charged as they come with stylish external, interchangeable bezels with built-in rechargeable batteries and come in a variety of colors, patterns and finishes.

More on The PennZone
  • Compliance Is the Ticket to Entry: Legal Advisor Gabriela Moraes Analyzes RWA Securitization Paths Under Brazil's New Legislation
  • Coalition and CCHR Call on FDA to Review Electroshock Device and Consider a Ban
  • Spark Announces 2025 Design Award Winners
  • NEW Luxury Single-Family Homes Coming Soon to Manalapan - Pre-Qualify Today for Priority Appointments
  • Together We Dance Shines at Newtown Holiday Parade

Netverse will be a verified, centralized-decentralized platform.

Centralized in the way it provides universal safeguards through verification of all users, businesses, organizations, entities and IP through Phinge's patented Netverse technologies and hardware.

Centralized because Phinge and Netverse will be compliant with all government regulations regarding data and privacy.

Decentralized because all third party platforms will be compliant with all government regulations regarding data and privacy as soon as they are verified and join Netverse.

Decentralized because its users, businesses, organizations and entities will have the power to live, work and thrive in a verified world.

Netverse will benefit all verified users and approved, verified third party businesses, developers and platforms on Netverse in ways not possible with today's technology including total verification of all users, businesses, organizations, platforms.

Contact
phinge corporation
***@phinge.com


Source: Phinge Corporation
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • 6 Holiday Looks That Scream "Old Money" But Cost Less Than Your Christmas Tree
  • Tickeron Launches Next-Gen AI Corridor Bots: Consistent Exits for Stocks and ETFs
  • From Cheer to Courtroom: The Hidden Legal Risks in Your Holiday Eggnog
  • Controversial Vegan Turns Rapper Launches First Song, "Psychopathic Tendencies."
  • Inside the Fight for Affordable Housing: Avery Headley Joins Terran Lamp for a Candid Bronx Leadership Conversation
  • Canterbury Hotel Group Announces the Opening of the TownePlace Suites by Marriott Portland Airport
  • Heritage at South Brunswick's Resort-Style Amenities for Any Age and Every Lifestyle
  • T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
  • Hummell Brothers Celebrates 100 Years as Trusted Lighting Store in Jeannette
  • Record Revenues, Debt-Free Momentum & Shareholder Dividend Ignite Investor Attention Ahead of 2026–2027 Growth Targets: IQSTEL (N A S D A Q: IQST)
  • New YouTube Channel Pair Launches to Bring Entertainment Nostalgia Back to Life
  • BRAG Hosts Holiday Benefit — Awards 10 Student Scholarships & Honors Timberland with the Corporate Impact Award
  • FittingPros Launches Industry's First Data-Driven Golf Club Fitting Directory
  • African American Genealogy Group Launches 2025 Raffle Fundraiser to Support Legacy Research
  • Take Control of Your Color Matching with Boston Industrial Solutions' Newly Expanded Natron® UVPX Series Ink Colors
  • "Dr. Vincent Michael Malfitano Expands Monterey–Sicily Cultural Diplomacy With Major International Media Engagement"
  • Kaufman Development Breaks Ground on Detroit Micro Data Center, Expanding Its National AI Platform
  • Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
  • $80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
  • High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030

Popular on PennZone

  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 538
  • BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers - 217
  • Light Her Way Launches New Cohort of Board of AdviseHERS to Prepare Women for Board-Ready Leadership - 104
  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • Corcoran DeRonja Real Estate Welcomes Siobhán Simões to Its Growing Team
  • Heritage At Manalapan - A New Luxury Single Family Home Community Coming Late 2025
  • BITE Data raises $3m to build AI tools for global trade compliance teams
  • purelyIV Expands Wellness Services with Flu/COVID Testing and Menopause Coaching & Treatment
  • CCHR Supports Call to End Coercive Psychiatry at World Mental Health Congress
  • Turbo vs. Experts: Tracking OddsTrader's AI Performance at the NFL's Midpoint

Similar on PennZone

  • Naturism Resurgence (NRE) Announces the World's First Standardised Stigma Measure (SSM) for Naturism
  • myLAB Box Expands, Becoming the First and Only At-Home Testing Company to Serve the Entire Family—Human and Furry—with New Pet Intolerance Test
  • Philadelphia Startup NoPlex Creates an ADHD/Neurodiversity-Focused Alternative to Productivity Apps
  • Tiger-Rock Martial Arts Appoints Jami Bond as Vice President of Growth
  • Super League (N A S D A Q: SLE) Enters Breakout Phase: New Partnerships, Zero Debt & $20 Million Growth Capital Position Company for 2026 Acceleration
  • Private Keys Are a Single Point of Failure: Security Advisor Gideon Cohen Warns MPC Technology Is Now the Only Defense for Institutional Custody
  • Compliance Is the Ticket to Entry: Legal Advisor Gabriela Moraes Analyzes RWA Securitization Paths Under Brazil's New Legislation
  • Coalition and CCHR Call on FDA to Review Electroshock Device and Consider a Ban
  • Anderson Periodontal Wellness Attends 5th Joint Congress for Ceramic Implantology
  • AI Real Estate Company Quietly Building a National Powerhouse: reAlpha Tech Corp. (N A S D A Q: AIRE)
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us